Sue Desmond-Hellmann: A smarter, more precise way to think about public health
Sue Desmond-Hellmann: Un mod mai inteligent și mult mai precis de a ne gândi la sănătatea publică
Sue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person. Full bio
Double-click the English transcript below to play the video.
Theresa Marie.
Theresa Marie.
and Kevin Michael's on his right.
iar Kevin Michael în dreapta lui.
să cresc într-o familie mare.
was picking names.
era să alegem nume.
number seven came along,
și copilul numărul șapte,
on Jennifer Bridget.
am ales Jennifer Bridget.
ceremonial moment.
acel moment ceremonial special.
for their new babies
pentru bebelușii lor
of this special ceremonial time?
acest moment ceremonial special?
bearable without a name.
puțin mai suportabilă fără un nume.
i-ar putea ajuta să se simtă
dreaming of the future of that child --
visând la viitorul unui copil –
of a future for their child
la viitorul copilului lor
pur și simplu nu știm.
an updated pie chart.
o diagramă actualizată.
under five worldwide."
sub cinci ani în întreaga lume.”
of that pie chart, about 40 percent --
în acea diagramă, cam 40% –
is less than one month old.
are mai puțin de o lună.
"We have no idea."
„Nu avem nicio idee.”
what you can't define.
the dreams of those parents
redarea speranței acelor părinți
about a new approach,
despre o nouă abordare,
know why babies are dying,
să aflăm de ce mor bebelușii,
from a very special place.
are o conotație specială.
an oncologist.
to help people feel better.
să îi ajut pe oameni să se simtă mai bine.
made them feel worse.
îi făceau să se simtă și mai rău.
being driven to my clinic
aduse la clinica mea
into my exam room by their mothers.
pentru a intra în sala de examinare.
pe care îl administrasem.
in the war on cancer,
în războiul cu cancerul
couldn't differentiate
nu puteau diferenția
that we wanted to hit hard
voiam să le distrugem
that we wanted to preserve.
pe care voiam să le păstrăm.
sunteți toți foarte familiarizați –
all very familiar with --
so infection was a constant threat --
cu amenințarea continuă a infecțiilor –
to the biotechnology industry.
în industria biotehnologiei.
for breast cancer patients
pentru pacientele cu cancer de sân
of telling the healthy cells
celulele sănătoase de cele canceroase.
HER2-positive breast cancer,
cancerul de sân HER-2 pozitiv,
form of breast cancer.
formă de cancer de sân.
hit hard the cancer cells,
să atacăm puternic celulele canceroase,
gentle on the normal cells.
cu celulele normale.
gene sequencing and more --
pacienților, secvențierea genetică etc. –
la momentul potrivit.
revolutionized cancer therapy.
terapia în cancer.
better way to tackle diseases
mai precisă de a combate bolile
expensive medicines like Herceptin
medicamentelor scumple precum Herceptin
targeting for individuals
aplicate la nivel individual
de sănătate publică
you're thinking, "She's crazy.
vă gândiți: „E nebună.
E un plan prea ambițios.”
to make a big difference.
as a cancer doctor.
who trained in San Francisco in the '80s,
în San Francisco în anii '80,
o pregătire pentru SIDA.
a terrible global challenge.
o provocare globală cumplită.
are living with HIV.
de femei trăiesc cu HIV.
become pregnant,
rămân însărcinate,
until the age of two.
până la vârsta de doi ani.
can virtually guarantee
poate practic garanta
the virus to the baby.
kind of like that blast of chemo,
în genul exploziei cu chimioterapice,
every pregnant woman in the world.
fiecare femeie însărcinată din lume.
where HIV rates are the highest.
unde incidența HIV este cea mai crescută.
in sub-Saharan Africa
din Africa Subsahariană
where rates are highest.
unde procentul este cel mai mare.
to a public health problem
a unei probleme de sănătate publică
in certain areas in the developing world
anumite zone în curs de dezvoltare
can change things on a big scale.
poate schimba lucruri la scală mare.
elements of precision public health:
pentru sănătate publică de precizie:
to the 2.6 million babies
la cei 2,6 milioane de bebeluși
pur și simplu nu știm.
the causes of infant mortality
de cauzele mortalității infantile
with the highest infant mortality
who has just lost her child,
mama care tocmai și-a pierdut copilul:
Did they have a fever?"
A avut febră?”
after the baby has died.
in the shoes of that mom.
excruciating conversation.
there was a fever or vomiting,
că a avut febră sau a vomitat
that knowledge,
a precision public health approach?
precizia sănătății publice?
because of a bacterial infection
unei infecții bacteriene
mom has a seven times higher chance
există un risc de șapte ori mai mare
we can prevent that death
putem preveni acea moarte
and safe as penicillin.
precum penicilina.
în acest caz am ști.
the right interventions
in the right places
în locurile corecte
and with these interventions
și cu aceste intervenții
a preciziei sănătății publice
our 15-year goal.
să ne atingem țelul în 15 ani.
into a million babies' lives saved
printr-un milion de bebeluși salvați
to public health --
a sănătății publice –
tackle malnutrition?
în lupta cu malnutriția?
cervical cancer in women?
cancerul cervical la femei?
in two different worlds,
by public health professionals.
de profesioniști în sănătate publică.
cu toții trăim în două lumi:
about precision public health
cel mai mult mă entuziasmează
talent and tools --
in ways I never imagined
pe care nu mi le-am imaginat vreodată
that kind of talent and tools
de acele talente și instrumente
din lumea săracă.
the confidence
ar putea avea siguranța
the moment that child is born,
atunci când se naște,
will be measured in decades,
va fi măsurată în decenii
ABOUT THE SPEAKER
Sue Desmond-Hellmann - CEO, Gates FoundationSue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person.
Why you should listen
As CEO of the Bill & Melinda Gates Foundation, Sue Desmond-Hellmann leads the organization's vision for a world where every person has the opportunity to live a healthy, productive life. Drawing on her diverse experience as scientist, physician and business executive, she oversees a variety of missions focused on eradicating disease, poverty and inequity. She leads 1,400 people, across four continents, working in more than 100 countries to help more children and young people survive and thrive, combat infectious diseases that hit the poorest hardest, and empower people -- particularly women and girls -- to transform their lives.
Trained as an oncologist, Dr. Desmond-Hellmann spent 14 years at biotech firm Genentech, developing a number of breakthrough medicines, including two of the first gene-targeted therapies for cancer, Avastin and Herceptin. In November 2009, Forbes magazine named her one of the world's seven most "powerful innovators," calling her "a hero to legions of cancer patients." Her time at Genentech put her at the forefront of the precision medicine revolution, and in her current role she champions a similar approach to global development: precision public health -- getting the right interventions, to the right populations, in the right places, to save lives.
Immediately prior to joining the foundation in 2014, Dr. Desmond-Hellmann was the first female chancellor of the University of California at San Francisco (UCSF), overseeing all aspects of the university and medical center's strategy and operations. It was her second stint at UCSF, having completed her clinical training there in the 1980s. She moved to Uganda in 1989 to work on HIV/AIDS and cancer, which she credits as a turning point in her career. "It was so profound to recognize ... that all the learning I had done to become a doctor didn't matter at all if I didn’t make a contribution," she said.
Dr. Desmond-Hellmann is the recipient of numerous honors and awards. She was listed among Fortune magazine's "50 most powerful women in business" for seven years. In 2010, she was inducted into the American Academy of Arts and Sciences and elected to the Institute of Medicine. She serves on the boards of directors at Facebook Inc. and the Procter & Gamble Company.
Sue Desmond-Hellmann | Speaker | TED.com